Skip to main content
. 2023 Mar 21;13(6):1974–2014. doi: 10.7150/thno.80887

Figure 13.

Figure 13

(A) Synthetic process and mechanism diagram of enhancing SDT and overcoming cancer drug resistance of mZMD. Reproduced with permission 217. Copyright 2022, Wiley-VCH. (B) Schematic illustration of 1064 nm light-activated NIR-II phototheranostic nanoplatform (BTZ/Fe2+@BTF/ALD) for combined NIR-II PTT/chemotherapy/CDT of breast cancer bone metastases. Reproduced under the terms of the http://creativecommons.org/licenses/by/4.0/ License 221, published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.